Improved lentiviral vectors for haematopoietic stem cell gene therapy of Mucopolysaccharidosis Type IIIA (MPSIIIA)

被引：0
|
作者：
Sergijenko, A. [1 ]
Langford-Smith, A. [1 ]
Langford-Smith, K. [1 ]
Wynn, R. [2 ]
Wraith, E. [3 ]
Jones, S. [3 ]
Wilkinson, F. [1 ]
Bigger, B. [1 ]
机构：
[1] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England
[2] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 1HA, Lancs, England
[3] St Marys Hosp, Manchester M13 0JH, Lancs, England
来源：
HUMAN GENE THERAPY | 2011年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A52 / A53
页数：2
相关论文
共 50 条
  • [31] Lentiviral Vectors in Gene and Cell Therapy Approaches
    Anton, Martina
    HUMAN GENE THERAPY, 2010, 21 (09) : 1170 - 1170
  • [32] Lentiviral Vector Mediated Haematopoietic Stem Cell Gene Therapy for the Treatment of Lysosomal Disease
    McDermott, J. H.
    Langford-Smith, A.
    Sergijenko, A.
    Langford-Smith, K. J.
    Liao, A.
    Jones, S. A.
    Wraith, J. E.
    Wynn, R. F.
    Wilkinson, F. W.
    Bigger, B. W.
    JOURNAL OF PATHOLOGY, 2013, 231 : 20 - 20
  • [33] Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA
    Ellison, Stuart M.
    Liao, Aiyin
    Wood, Shaun
    Taylor, Jessica
    Youshani, Amir Saam
    Rowlston, Sam
    Parker, Helen
    Armant, Myriam
    Biffi, Alessandra
    Chang, Lucas
    Farzaneh, Farzin
    Wynn, Rob
    Jones, Simon A.
    Heal, Paul
    Gaspar, H. Bobby
    Bigger, Brian W.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 399 - 413
  • [34] Ex vivo lentiviral gene therapy for mucopolysaccharidosis type IVA
    Celik, Betul
    Rintz, Estera
    Nidhi, Fnu
    Khan, Shaukat
    Tomatsu, Shunji
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [35] Transient manipulation of haematopoietic stem cells with integrative deficient lentiviral vectors for improved cell expansion, survival and engraftment
    Alonso-Ferrero, M. E.
    Bartolovic, K.
    Kinnon, C.
    Mata, M.
    Milsom, M. D.
    vanTil, N. P.
    Howe, S. J.
    HUMAN GENE THERAPY, 2013, 24 (12) : A35 - A35
  • [36] AAVance gene therapy study in children with mucopolysaccharidosis type IIIA
    Laufer, Ralph
    Drevot, Philippe
    Hocquemiller, Michael
    Deleglise, Berangere
    Deneux, Marie
    Pignet-Aiach, Karen
    Frapaise, Xavier
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S71 - S72
  • [37] BIOCHEMICAL ENGRAFTMENT AND CLINICAL OUTCOMES OF EX-VIVO AUTOLOGOUS STEM CELL GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE IIIA
    Guha, Anthea
    Wynn, Robert
    Bigger, Brian
    Kinsella, Jane
    Holley, Rebecca
    Potter, Jane
    Ellison, Stuart
    Thrasher, Adrian
    Booth, Kathryn
    Buckland, Karen
    Izotova, Natalia
    Rust, Stewart
    Weisberg, Daniel
    Church, Heather
    Tylee, Karen
    Brammeier, Kathryn
    Jones, Simon
    Lee, Helena
    Ford, Laura
    Sadegholnejat, Atusa
    Jones, Ceri
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 62 - 63
  • [38] Transient manipulation of haematopoietic stem cells with integrative deficient lentiviral vectors for improved cell expansion, survival and engraftment
    Alonso-Ferrero, Maria E.
    Bartolovic, Kerol
    Kinnon, Christine
    Mata, Marcia
    Van Til, Niek P.
    Howe, Steven J.
    HUMAN GENE THERAPY, 2012, 23 (05) : A14 - A14
  • [39] Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice
    Langford-Smith, Alexander
    Wilkinson, Fiona L.
    Langford-Smith, Kia J.
    Holley, Rebecca J.
    Sergijenko, Ana
    Howe, Steven J.
    Bennett, William R.
    Jones, Simon A.
    Wraith, J. E.
    Merry, Catherine L. R.
    Wynn, Robert F.
    Bigger, Brian W.
    MOLECULAR THERAPY, 2012, 20 (08) : 1610 - 1621
  • [40] Haematopoietic Stem Cell Gene Therapy Combined with an Anti-Inflammatory to Correct Mucopolysaccharidosis IIIB
    Bigger, Brian
    MOLECULAR THERAPY, 2017, 25 (05) : 309 - 309
12345